Skip to main content
VulnerabilityPublished

CVE-2026-41908: OpenClaw · Incorrect Authorization

Affects OpenClawSource GCVE Database

0
Compare

Not known to be exploited · CVSS 2.3 Low : upgrade to 2026.4.20 when convenient.

Data as of 12 Nov 2026, 01:03 UTC

CVSS 4.0 base score
2.3Low
How severe the flaw is on the 0–10 CVSS scale.

Thin evidence

One scorer or none
CVSS scores by source
CNA (VulnCheck)CVSS 4.02.3
CNA (VulnCheck)CVSS 3.14.3
Patch
Available – fixed in 2026.4.20
CVSS:4.0/AV:N/AC:L/AT:P/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 23 Apr 2026

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponized: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 11 Nov 2026.

What to do

Upgrade OpenClaw to 2026.4.20.

Affected software

ProductAffectedFixed in
OpenClaw OpenClawAffected
  • <2026.4.20
Fixed in
  • 2026.4.20

AI-suggested

A fix is available in OpenClaw version 2026.4.20 and later. Users should upgrade to this version or later to remediate the scope enforcement bypass vulnerability. No additional mitigation guidance is provided or required beyond applying the official fix.

Description

OpenClaw versions before 2026.4.20 have an authorization bypass vulnerability in the assistant-media route. This flaw allows trusted-proxy callers lacking the operator.read scope to access protected assistant-media files and metadata by bypassing HTTP authentication scope validation. The vulnerability enables unauthorized retrieval of sensitive media content within allowed media roots. The CVSS 4.0 base score is 2.3, indicating low severity.

References

Community reviews

Loading reviews…